Roxane Wants DOJ Sanctioned For Spoliation
The U.S. Department of Justice allegedly spoliated evidence in the average wholesale price antitrust litigation that could reduce Boehringer Ingelheim Roxane Inc.'s damages by up to $1 billion, the pharmaceutical company...To view the full article, register now.
Already a subscriber? Click here to view full article